NCT01384422View on ClinicalTrials.gov

Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

GLPG0634

Trial Locations (1)

MD-2025

Innophar MO S.R.L., Chisinau

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY